Patrick Frost, PhD

Patrick Frost, PhD

Feb 10, 2016

Group 6 Copy 65
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Low cost snake antivenom for Asia, Africa and South America

Death by snake venom in India, Africa, and South America are substantial. Traditional antidotes are prohibitively...

Using Gene Therapy to Target and Treat Cancers

Non-coding RNAs regulate levels of gene expression in cells, meaning that we now have a unique tool that...

Backer Badge Funded